Analyst Ratings For Evoke Pharma (NASDAQ:EVOK)
Today, HC Wainwright reiterated its Buy rating on Evoke Pharma (NASDAQ:EVOK) with a price target of $9.00.
Some recent analyst ratings include
- 3/6/2018-HC Wainwright Reiterated Rating of Buy.
- 11/15/2017-B. Riley Reiterated Rating of Buy.
- 10/30/2017-FBR & Co Reiterated Rating of Buy.
- 10/18/2017-Northland Securities Reiterated Rating of Buy.
- 10/6/2017-Seaport Global Securities Reiterated Rating of Buy.
- 3/16/2017-Rodman & Renshaw Reiterated Rating of Buy .
Recent Insider Trading Activity For Evoke Pharma (NASDAQ:EVOK)
Evoke Pharma (NASDAQ:EVOK) has insider ownership of 20.00% and institutional ownership of 18.71%.
- On 2/22/2017 Kenneth J Widder, Director, bought 450,000 with an average share price of $2.90 per share and the total transaction amounting to $1,305,000.00.
- On 5/26/2016 Parters Vii L P Domain, Major Shareholder, sold 344,120 with an average share price of $4.70 per share and the total transaction amounting to $1,617,364.00.
- On 4/27/2016 Parters Vii L P Domain, Major Shareholder, sold 5,095 with an average share price of $5.07 per share and the total transaction amounting to $25,831.65.
- On 4/25/2016 Parters Vii L P Domain, Major Shareholder, sold 1,492 with an average share price of $5.20 per share and the total transaction amounting to $7,758.40.
- On 4/20/2016 Parters Vii L P Domain, Major Shareholder, sold 41,478 with an average share price of $5.35 per share and the total transaction amounting to $221,907.30.
- On 4/11/2016 Parters Vii L P Domain, Major Shareholder, sold 4,348 with an average share price of $5.22 per share and the total transaction amounting to $22,696.56.
- On 4/8/2016 Parters Vii L P Domain, Major Shareholder, sold 51,004 with an average share price of $5.28 per share and the total transaction amounting to $269,301.12.
Recent Trading Activity for Evoke Pharma (NASDAQ:EVOK)
Shares of Evoke Pharma closed the previous trading session at with shares trading hands.
